Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Clinical Trials in China

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University481 Fudan University478 Second Affiliated Hospital, Zhejiang University, School of Medicine401 Ruijin Hospital289 Peking Union Medical College Hospital279
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials in this register

19187 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Peking Union Medical College Hospital
Observational
180
Beijing
2020-12-06
Active, closed
Daiichi Sankyo
Phase 3
1,600
Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin
2020-12-04
Active, closed
Amgen
Phase 3
135
Hohhot, Beijing, Guandong, Shang’ai, Shenyang, Wuhan
2020-12-04
Recruiting
Zhejiang University
Phase 2
40
Hangzhou
2020-12-03
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shenzhen
2020-12-02
Recruiting
Zhejiang University
Not applicable
1,000
Hangzhou
2020-12-01
Recruiting
Hui-Sheng Chen
Not applicable
30
Shenyang
2020-12-01
Active, closed
Children's Hospital of Fudan University
Not applicable
40
Shanghai
2020-12-01
Recruiting
Children's Hospital of Fudan University
Observational
90
Shanghai
2020-12-01
Recruiting
Sun Yat-sen University
Phase 2
80
Guangzhou
2020-12-01
Recruiting
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
NCT04743479Pancreatic Cancer, Diabetes, Familial Pancreatic Cancer, Pancreatic Cystic Neoplasm
Changhai Hospital
Observational
5,000
Shanghai
2020-12-01
Recruiting
Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET)
NCT04664933Stroke, Ischemic, Intravascular Thrombosis, Mechanical Thrombectomy
Hui-Sheng Chen
Not applicable
30
Shenyang
2020-12-01
Recruiting
Binhui Biopharmaceutical Co., Ltd.
Phase 1/2
60
Beijing
2020-12-01
Recruiting
Ruijin Hospital
Observational
2,000
Shanghai
2020-12-01
Active, closed
Postoperative Thrombosis Prevention in Patients With CD
NCT04486859Cushing Disease, DVT, Pulmonary Embolism
Huashan Hospital
Not applicable
206
Fuzhou, Guangzhou, Wuhan, Shanghai, Chengdu, Ürümqi, Beijing
2020-12-01
Recruiting
National Longitudinal Cohort of Hematological Diseases
NCT04645199Multiple Myeloma, Acute Myeloid Leukemia, Hemophilia, Hemophilia A
Institute of Hematology & Blood Diseases Hospital, China
Observational
2,300
Tianjin
2020-12-01
Recruiting
Shenzhen Hemogen
Early Phase 1
10
Shenzhen
2020-12-01
Recruiting
PUMCH Dementia Longitudinal Cohort Study
NCT05023564Dementia, Dementia, Vascular, Dementia With Lewy Bodies, Dementia, Mixed
Peking Union Medical College Hospital
Observational
20,000
Beijing
2020-12-01
Recruiting
Myocardial Infarction and Periodontitis: Periodontal Health Intervention.
NCT06745141Acute Myocardial Infarction (AMI), Periodontal Disease
Shanghai 10th People's Hospital
Not applicable
100
Shanghai
2020-12-01
Active, closed
Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer
NCT04516616Uterine Cervical Neoplasm, Uterine Cervical Cancer, Cervical Cancer
DrugsAlbumin-Bound Paclitaxel·Cisplatin
Huazhong University of Science and Technology
Phase 2
85
Wuhan
2020-12-01
Recruiting
Relationship Between "FODMAPs" and "GVHD"
NCT04660487Graft Versus Host Disease
The First Affiliated Hospital of Soochow University
Observational
100
Suzhou
2020-12-01
Recruiting
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
NCT07205510Sarcopenia, Metabolic Diseases, All-cause Mortality, Aging
RenJi Hospital
Observational
10,000
Shanghai
2020-12-01
By invitation
Guangzhou Women and Children's Medical Center
Observational
100
Guangzhou
2020-12-01
Recruiting
Durg Coated Balloon Angioplasty in Infrapopliteal Lesions
NCT05620095Arteriosclerosis, Peripheral Artery Disease, Chronic Limb Threatening Ischemia
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Observational
1,000
Beijing, Wuhan, Suzhou, Qingdao, Shanghai, Chengdu, Hangzhou
2020-12-01
Not yet open
Peking University
Observational
1,030
Beijing
2020-12-01
Recruiting
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT05740995Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy
DrugNeoadjuvant anti-PD-1
Shanghai Zhongshan Hospital
Observational
40
Shanghai
2020-12-01
Active, closed
Sun Yat-sen University
Phase 2
42
Guangzhou
2020-12-01
Recruiting
Shanghai Yueyang Integrated Medicine Hospital
Observational
1,078
Shanghai
2020-12-01
Recruiting
China Medical University Hospital
Phase 2
90
2020-11-30
Active, closed
Hoffmann-La Roche
Phase 2
303
Changchun, Guangzhou, Linyi, Nanchang, Shanghai, Tianjin, Wuhan, Xi'an
2020-11-27
Active, closed
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
42
Hangzhou
2020-11-23
Active, closed
Gilead Sciences
Phase 3
331
Beijing, Changchun, Chengdu, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan
2020-11-23
Active, closed
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasms (MPNs)
DrugsLY3410738·Azacitidine·Venetoclax
Eli Lilly and Company
Phase 1
260
2020-11-19
Recruiting
Hebei Medical University Fourth Hospital
Observational
620
Shijiazhuang
2020-11-19
Recruiting
Sun Yat-sen University
Phase 2
43
Guangzhou
2020-11-17
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
DrugsPrifetrastat·Atirmociclib·Palbociclib·Letrozole
Pfizer
Phase 2
320
Beijing, Guangzhou, Changchun, Xi'an
2020-11-16
Not yet open
CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma
NCT04609241Relapsed and/or Refractory Acute Lymphoblastic Leukemia, Relapsed and/or Refractory B-cell Non-Hodgkin's Lymphoma
Zhejiang University
Early Phase 1
72
Hangzhou
2020-11-15
Not yet open
Zhejiang University
Early Phase 1
36
Hangzhou
2020-11-15
Recruiting
Fudan University
Phase 2
51
Shanghai
2020-11-13
Recruiting
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
579
Jinan, Shanghai, Mianyang, Wenzhou
2020-11-12
Recruiting
EUS Guided Portal-systemic Pressure Gradient Measurement
NCT04633356Portal Hypertension, Cirrhosis
Chinese University of Hong Kong
Phase 1/2
30
Hong Kong
2020-11-12
Recruiting
Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM)
NCT06219083Cancer, Chemoradiotherapy, Nutrition, Healthy, Oncology
Xiaoqin Luo
Observational
1,538
Xi'an
2020-11-12
Active, closed
AstraZeneca
Phase 1/2
702
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Harbin, Jining
2020-11-12
Active, closed
Hecheng Li M.D., Ph.D
Phase 3
244
Shanghai, Hangzhou, Ningbo
2020-11-10
Active, closed
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
60
Beijing, Chongqing, Xiamen, Zhengzhou, Wuhan, Shanghai, Chengdu
2020-11-10
Active, closed
Fujian Medical University
Not applicable
1,070
Fuzhou
2020-11-10
Active, closed
Guangzhou Medical University
Observational
30
Guangzhou
2020-11-06
Active, closed
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
47
Hefei, Beijing, Chongqing, Guangzhou, Changsha, Shanghai, Tianjin, Hangzhou
2020-11-04
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
281
Beijing, Guangzhou, Hangzhou, Shanghai, Suzhou, Wenzhou, Wuhan
2020-11-03
Recruiting
Prospective, Observational Real-world Treatments of AEDH in Large-scale Surgical Cases
NCT04229966Epidural Hematoma, Decompressive Craniectomy, Craniotomy
RenJi Hospital
Observational
2,000
Shanghai
2020-11-02
Recruiting
Huazhong University of Science and Technology
Not applicable
771
Wuhan
2020-11-02
Active, closed
Fudan University
Phase 2
100
Shanghai
2020-11-01
Recruiting
Surgical Intervention for Refractory Granulomatous Lobular Mastitis
NCT04637711Refractory Granulomatous Lobular Mastitis
Wuhan University
Not applicable
300
Wuhan
2020-11-01
Recruiting
Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
NCT04770207Hepatocellular Carcinoma, Solid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University
Phase 2
100
Guangzhou
2020-11-01
Recruiting
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
1,000
Beijing
2020-11-01
Active, closed
Hoffmann-La Roche
Phase 1/2
518
Beijing, Shanghai
2020-11-01
Recruiting
Sun Yat-sen University
Phase 3
500
Guangzhou
2020-11-01
By invitation
Fujian Provincial Hospital
Observational
35
Fuzhou
2020-11-01
Active, closed
Zhongda Hospital
Observational
1,136
Nanjing
2020-10-28
Active, closed
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
NCT04452591Non Muscle Invasive Bladder Cancer, High-grade Ta/ T1 Papillary Disease Bladder Cancer
DrugCretostimogene Grenadenorepvec
CG Oncology, Inc.
Phase 3
190
2020-10-27
Recruiting
Juventas Cell Therapy Ltd.
Phase 2
60
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Jinan, Shanghai, Chengdu
2020-10-26
Recruiting
Abbott Vascular Medical Device Registry
NCT04573660Acute Myocardial Infarction, Restenoses, Coronary, Coronary Artery Lesions, Venous Embolism
Abbott Medical Devices
Observational
3,784
Xi'an, Jinhua, Ningbo
2020-10-25
Recruiting
Toripalimab Combined With CAV/IE Regimen
NCT04589741Soft Tissue Sarcoma
DrugToripalimab
Sun Yat-sen University
Phase 2
134
Guangzhou
2020-10-23
Active, closed
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
NCT04581473Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma
DrugsCT041 autologous CAR T-cell·Apatinib·Irinotecan
CARsgen Therapeutics Co., Ltd.
Phase 1/2
192
Hefei, Beijing, Fuzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Nanjing
2020-10-23
Active, closed
Gilead Sciences
Phase 2
80
Beijing, Shenyang, Hangzhou, Changchun, Changsha, Chengdu, Chongqing, Guangzhou
2020-10-23
Active, closed
Bayer
Phase 3
774
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shantou, Shenzhen
2020-10-20
Active, closed
AstraZeneca
Phase 3
640
Anyang, Beijing, Bengbu, Changsha, Changzhi, Chengdu, Chongqing, Fuzhou
2020-10-19
Recruiting
Shanghai Proton and Heavy Ion Center
Phase 2
140
Shanghai
2020-10-15
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
DrugInebilizumab
Amgen
Phase 3
238
Beijing, Guiyang, Hunan, Jinan, Shanghai, Suzhou, Tianjin, Xi'an
2020-10-15
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
516
Guangzhou
2020-10-14
Recruiting
TCM Biotech International Corp.
Phase 3
348
2020-10-14
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Guangzhou
2020-10-13
Recruiting
China Medical University Hospital
Phase 2
60
2020-10-13
Recruiting
Yu Shi
Observational
200
Shenyang
2020-10-09
Recruiting
Assess the Risk of Cerebrovascular Disease
NCT04443439Cerebrovascular Disease
Tang-Du Hospital
Observational
100
Xi'an
2020-10-09
Active, closed
Hoffmann-La Roche
Phase 3
992
Anyang, Baoding, Beijing, Bengbu, Changchun, Changsha, Fujian, Guangzhou
2020-10-09
Recruiting
MRE for Diagnosis of Pancreatic Masses
NCT06526442Pancreatic Neoplasm, Magnetic Resonance Imaging
Yu Shi
Observational
200
Shenyang
2020-10-09
Active, closed
Hoffmann-La Roche
Phase 3
210
Beijing, Guangzhou, Hangzhou, Nanjing, Nantong, Shanghai, Wuhan
2020-10-08
Active, closed
Acerta Pharma BV
Phase 3
611
Beijing, Changchun, Chengdu, Guangzhou, Hangzhou, Harbin, Jinan, Luoyang
2020-10-08
Recruiting
China Imaging-based Biobank of Cerebral Small Vessal Diseases
NCT04962295Cerebral Small Vessel Diseases
Peking University Third Hospital
Observational
10,000
Beijing
2020-10-01
Recruiting
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
NCT04528511Atrial Fibrillation New Onset, Acute Myocardial Infarction
Shanghai 10th People's Hospital
Observational
774
Kaifeng, Luoyang, Zhengzhou, Shanghai
2020-10-01
Active, closed
Eli Lilly and Company
Phase 1
200
2020-10-01
Recruiting
West China Hospital
Observational
1,500
Chengdu
2020-10-01
Active, closed
GlaxoSmithKline
Phase 3
302
Beijing, Changchun, Changsha, Guangzhou, Hangzhou, Jiangsu, Nanchang, Shenyang
2020-10-01
Not yet open
Colorectal Adenoma Canceration in FAP
NCT04531930Familial Adenomatous Polyposis
Changhai Hospital
Observational
124
Shanghai
2020-10-01
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Guangzhou, Hangzhou
2020-09-30
Active, closed
AbbVie
Phase 3
527
Hefei, Beijing, Chongqing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Changsha
2020-09-30
Active, closed
Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia
NCT04562558Gestational Trophoblastic Tumor, Gestational Trophoblastic Neoplasia, Stage I Gestational Trophoblastic Tumor, Stage II Gestational Trophoblastic Tumor
DrugsDactinomycin·Leucovorin·Methotrexate
xiang yang
Not applicable
228
Beijing
2020-09-29
Recruiting
RemeGen Co., Ltd.
Phase 3
366
Beijing
2020-09-29
Active, closed
Ruihua Wei
Observational
3,000
Tianjin
2020-09-28
Recruiting
Ascentage Pharma Group Inc.
Phase 1/2
682
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Suzhou, Shanghai
2020-09-28
Recruiting
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2
310
Hefei, Beijing, Guangzhou, Zhuhai, Guangdong, Shijiazhuang, Harbin, Luoyang
2020-09-27
Active, closed
Daiichi Sankyo Co., Ltd.
Phase 3
40
Beijing, Guangzhou, Hangzhou, Shanghai
2020-09-25
Recruiting
Phase Ib Clinical Study of Keynatinib
NCT04807881Lymphoma, B-Cell
Medolution Ltd.
Phase 1
75
Beijing, Shanghai, Chengdu
2020-09-24
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanchang, Nanjing, Ningbo
2020-09-23
Recruiting
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
NCT04557449Liposarcoma, Prostate Cancer, Advanced Breast Cancer, NSCLC (Non-small Cell Lung Cancer)
DrugAtirmociclib
Pfizer
Phase 1/2
430
Beijing, Zhengzhou, Wuhan, Xi’an, Hangzhou
2020-09-23
Active, closed
Peking Union Medical College Hospital
Phase 2
20
Beijing
2020-09-23
Recruiting
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
NCT04561557Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder, Myasthenia Gravis
DrugCyclophosphamide and Fludarabine
Tongji Hospital
Early Phase 1
36
Wuhan
2020-09-22
Recruiting
Pragmatic Trial of Obsessive-compulsive Disorder
NCT04539951Obsessive-Compulsive Disorder
DrugsFluvoxamine·Venlafaxine
Shanghai Mental Health Center
Phase 2
1,600
Shanghai
2020-09-22
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
550
Beijing
2020-09-21
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2/3
260
Hangzhou
2020-09-20
Active, closed
argenx
Phase 2
229
Beijing, Changsha, Chengdu, Chifeng, Fuzhou, Guangzhou, Guanzhou, Guiyang
2020-09-18
Active, closed
Janssen Research & Development, LLC
Phase 2
194
Beijing, Chengdu, Guangzhou, Hangzhou, Shanghai, Shenyang, Tianjin, Xi'an
2020-09-17
Active, closed
PF-07104091 as a Single Agent and in Combination Therapy
NCT04553133Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer
DrugsPF-07104091·Palbociclib·Letrozole·Fulvestrant
Pfizer
Phase 2
157
Shanghai, Tianjin
2020-09-16
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Beijing, Xiamen, Guangzhou, Zhengzhou, Changchun, Dalian, Shanghai, Chengdu
2020-09-16
Active, closed
The Second Affiliated Hospital of Fujian Medical University
Phase 2
29
Fuzhou
2020-09-16
Recruiting
Epygenix
Phase 3
150
Beijing, Chongqing, Guangzhou, Shenzhen, Guiyang, Wuhan, Changsha, Xuzhou
2020-09-15
Recruiting
Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)
NCT04998175Idiopathic Normal Pressure Hydrocephalus
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
40
Hangzhou
2020-09-15
Active, closed
AbbVie
Phase 3
531
Beijing, Lanzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Nanjing, Suzhou
2020-09-10
Recruiting
Ruijin Hospital
Not applicable
40
Shanghai
2020-09-10
Recruiting
Huashan Hospital
Observational
33,000
Shanghai
2020-09-09
Recruiting
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
NCT04511234Peripheral Artery Disease, Atherosclerosis, Arterial Disease
Concept Medical Inc.
Not applicable
279
2020-09-08
Active, closed
A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.
NCT05395533CD20-positive B-cell Non-Hodgkin Lymphoma
DrugTRS005
Zhejiang Teruisi Pharmaceutical Inc.
Phase 1
147
Beijing, Guangzhou, Zhengzhou, Suzhou, Tianjin
2020-09-08
Active, closed
Nanjing First Hospital, Nanjing Medical University
Not applicable
784
Nanjing
2020-09-08
Recruiting
Evaluate the Safety and Clinical Activity of HH2853
NCT04390737FL Lymphoma, Epithelioid Sarcoma, Peripheral T Cell Lymphoma, Advanced Solid Tumor
DrugHH2853
Haihe Biopharma Co., Ltd.
Phase 1/2
254
Hefei, Beijing, Guangzhou, Nanning, Zhengzhou, Wuhan, Changsha, Nanjing
2020-09-08
Active, closed
Xiamen University
Phase 3
9,327
Nanjing, Chengdu
2020-09-05
Recruiting
Atrial Fibrillation Patients Treated With Catheter Ablation
NCT05266144Atrial Fibrillation, Atrial Fibrillation Recurrent
Peking Union Medical College Hospital
Observational
300
Beijing
2020-09-04
Recruiting
HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma
NCT04353375Advanced Intrahepatic Cholangiocarcinoma, Solid Tumor, Adult
Hutchmed
Phase 2/3
235
Beijing
2020-09-03
Active, closed
Karyopharm Therapeutics Inc
Phase 2/3
501
Nanjing, Suzhou, Huangpu, Xuhui, Chengdu, Hangzhou
2020-09-03
Active, closed
Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC
NCT04699721Non-small Cell Lung Cancer Stage II, Non-small Cell Lung Cancer Stage ⅢA, Non-small Cell Lung Cancer Stage IIIB
DrugNivolumab
Xiangya Hospital of Central South University
Phase 2
65
Changsha
2020-09-02
Active, closed
Yanhong Deng
Phase 3
528
Guangzhou
2020-09-01
Active, closed
First Affiliated Hospital of Zhejiang University
Phase 3
232
Changsha, Chongqing, Hangzhou, Nanjing, Ningbo, Suzhou
2020-09-01
Recruiting
Fudan University
Observational
6,000
Shanghai
2020-09-01
Recruiting
Shanghai Zhongshan Hospital
Not applicable
1,500
Shanghai
2020-09-01
Recruiting
ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies
NCT04412616Advanced EGFR Positive Solid Tumor
Changchun Intellicrown Pharmaceutical Co. LTD
Phase 1
60
Changchun
2020-09-01
Recruiting
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
NCT04453826Nasopharyngeal Cancer, Chemotherapy, Radiotherapy, PD-1 Therapy
DrugCamrelizumab
Sun Yat-sen University
Phase 3
388
Guangzhou, Shaoguan, Zhongshan, Zhuhai, Wuzhou
2020-09-01
Recruiting
Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients
NCT06690970PSMA-related Disease, Prostate Cancer, Positron Emission Tomography, Metastasis
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2020-09-01
Recruiting
Preventive Effect of Limited Decompression on Adjacent Segment Following Posterior Lumbar Interbody Fusion
NCT04469387Degenerative Lumbar Spinal Stenosis, Degenerative Disc Disease, Degeneration Spine
Peking University Third Hospital
Not applicable
200
Beijing
2020-09-01
Recruiting
Beijing Tiantan Hospital
Observational
1,200
Beijing
2020-09-01
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
40
Shanghai
2020-09-01
Recruiting
First Affiliated Hospital of Fujian Medical University
Not applicable
100
Fuzhou
2020-09-01
Recruiting
MR Microstructural Imaging for Prostate Cancer Diagnosis
NCT07249281Prostate Cancer, Diffusion MRI
First Affiliated Hospital of Zhejiang University
Observational
2,000
Beijing, Zhengzhou, Nanjing, Dalian, Hangzhou
2020-09-01
Recruiting
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers
NCT06561906Alzheimer Disease, Late Onset, Mild Cognitive Impairment, Subjective Cognitive Decline
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
1,000
Nanjing
2020-09-01
Recruiting
The Risk Factors of Cardiovascular Disease in Elderly Diabetic Patients: A Prospective Cohort Study
NCT04544527Diabetes Mellitus, Cardiovascular Diseases, Complication Diabetic
Shanghai Zhongshan Hospital
Observational
10,000
Suzhou
2020-09-01
Active, closed
A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies
NCT04534023Rapid Eye Movement Sleep Behavior Disorder, Synucleinopathy
DrugIdebenone
Ruijin Hospital
Phase 2
28
Shanghai
2020-08-31
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
339
Nanjing
2020-08-31
Active, closed
AbbVie
Phase 3
330
2020-08-31
Recruiting
Ascentage Pharma Group Inc.
Phase 1/2
123
Beijing, Chongqing, Guangzhou, Nanning, Guiyang, Shijiazhuang, Zhenzhou, Wuhan
2020-08-31
Recruiting
Thrombus Aspiration in STEMI Patients With High Thrombus Burden
NCT04212494ST-segment Elevation Myocardial Infarction (STEMI)
Guangdong Provincial People's Hospital
Not applicable
3,838
Fuzhou, Foshan, Guangzhou, Huizhou, Jiangmen, Kaiping, Maoming, Shantou
2020-08-30
Active, closed
Dexmedetomidine and Outcomes of Elderly Admitted to ICU After Surgery
NCT04204798Elderly, Surgery, Intensive Care Unit, Dexmedetomidine
DrugDexmedetomidine
Peking University First Hospital
Not applicable
1,410
Beijing
2020-08-28
Recruiting
Capital Medical University
Observational
1,500
Beijing
2020-08-26
Active, closed
Ruijin Hospital
Phase 2
40
Shanghai
2020-08-26
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
125
Beijing, Guangzhou, Hangzhou, Wenzhou, Wuhan
2020-08-25
Active, closed
PharmaEssentia
Phase 3
174
Beijing, Chongqing, Guangzhou, Wuhan, Suzhou, Shenyang, Xi'an, Jinan
2020-08-25
Active, closed
Sun Yat-sen University
Not applicable
1,124
Chongqing, Lanzhou, Guangzhou, Shenzhen, Guilin, Zhengzhou, Wuhan, Nanjing
2020-08-25
Recruiting
Sun Yat-sen University
Phase 3
508
Guangzhou, Shaoguan, Zhongshan, Wuzhou
2020-08-18
Active, closed
Sun Yat-sen University
Phase 3
381
Guangzhou
2020-08-17
Recruiting
A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in China
NCT04573283Metabolic Associated Fatty Liver Disease
Nanfang Hospital, Southern Medical University
Observational
3,000
Guangzhou
2020-08-17
Recruiting
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365Tumor, Positron-Emission Tomography, Metastasis
First Affiliated Hospital of Fujian Medical University
Early Phase 1
500
Fuzhou
2020-08-15
Recruiting
The Cleveland Clinic
Phase 3
1,614
Shanghai
2020-08-15
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
770
Beijing
2020-08-15
Recruiting
SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease
NCT04511247Peripheral Artery Disease, Atherosclerosis, Arterial Disease of Legs
Concept Medical Inc.
Not applicable
219
2020-08-15
Active, closed
Transcenta Therapeutics (Hangzhou) Co., Ltd.
Phase 1/2
320
Bengbu, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Guangxi, Haikou
2020-08-13
Active, closed
Hoffmann-La Roche
Phase 1/2
237
Changchun, Chengdu, Shanghai, Tianjing, Xiamen
2020-08-12
Active, closed
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
648
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Wuwei
2020-08-11
Recruiting
Institute of Hematology & Blood Diseases Hospital, China
Phase 4
224
Tianjin
2020-08-10
Recruiting
First Affiliated Hospital of Fujian Medical University
Early Phase 1
50
Fuzhou
2020-08-07
Recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome
University of Siena
Observational
3,500
Beijing, Chongqing
2020-08-06
Active, closed
Ever Supreme Bio Technology Co., Ltd.
Phase 1/2
75
2020-08-05
Active, closed
AstraZeneca
Phase 3
185
Changchun
2020-08-04
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
460
Guandong
2020-08-03
Recruiting
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 3
352
Guangzhou
2020-08-01
Recruiting
Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock
NCT03948048Septic Shock, Extracorporeal Membrane Oxygenation Complication
Children's Hospital of Fudan University
Observational
60
Shanghai
2020-08-01
Recruiting
Clinical Study of Impact of Different Pacing Site in Patients
NCT04931550Bradyarrhythmias, Heart Failure, Pacemaker
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
600
Hangzhou
2020-08-01
Recruiting
RFA Plus Carrizumab vs Carrizumab Alone for HCC
NCT04150744Tumor Immunity, Immunosuppression, Radiofrequency Ablation
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
120
Hangzhou
2020-08-01
Active, closed
Shanghai Zhongshan Hospital
Phase 2
65
Shanghai
2020-08-01
Recruiting
Ruijin Hospital
Observational
1,000
Beijing, Hanzhong, Cangzhou, Shijiazhuang, Qingdao, Shanghai, Shenyang
2020-07-30
Active, closed
ASPIrin in Reducing Events in Dialysis ( ASPIRED )
NCT04381143CKD (Chronic Kidney Disease) Stage 5D
DrugAspirin
Guangdong Provincial People's Hospital
Phase 4
9,082
Fuzhou, Longyan, Lanzhou, Dongguan, Foshan, Guangzhou, Guanzhou, Heyuan
2020-07-30
Active, closed
Shengjing Hospital
Phase 2
89
Shenyang
2020-07-27
Recruiting
InxMed (Shanghai) Co., Ltd.
Phase 1/2
150
Anyang, Beijing, Changsha, Fuzhou, Hangzhou, Tianjin, Zhengzhou
2020-07-27
Active, closed
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
89
Shang'ai
2020-07-26
Active, closed
AstraZeneca
Phase 3
866
Baoding, Beijing, Changchun, Changsha, Dalian, Foshan, Fuzhou, Guangzhou
2020-07-24
Active, closed
AstraZeneca
Phase 3
134
Chengdu, Shanghai, Tianjin, Xiamen, Zhengzhou
2020-07-20
Active, closed
Novartis Pharmaceuticals
Phase 3
19
Changchun, Shanghai
2020-07-16
Recruiting
SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement
NCT04454177Aortic Stenosis, Valvular Heart Disease, Transcatheter Aortic Valve Replacement
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
100
Hangzhou
2020-07-15
Active, closed
GlaxoSmithKline
Phase 3
242
Beijing, Changchun, Chongqing, Guangzhou, Nanchang, Nanjing, Shanghai, Tianjin
2020-07-14
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
537
Beijing, Guangzhou, Zhengzhou, Nanjing, Shanghai, Chengdu, Hangzhou
2020-07-14
Recruiting
Peking Union Medical College Hospital
Observational
150
Beijing
2020-07-13
Active, closed
AstraZeneca
Phase 3
1,012
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang
2020-07-13
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
10,000
Hangzhou, Beijing, Chongqing, Fujian, Gansu, Guangdong, Guangxi, Guizhou
2020-07-08
Recruiting
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
50
Tianjin
2020-07-08
Active, closed
Nuvation Bio Inc.
Phase 2
173
Shanghai
2020-07-07
Recruiting
Fudan University
Phase 2
25
Shanghai
2020-07-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Beijing, Chongqing, Fuzhou, Xiamen, Shenzhen, Zhengzhou, Wuhan, Changsha
2020-07-06
Recruiting
Peking University
Not applicable
136
Beijing
2020-07-03
Recruiting
Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma
NCT04453813Nasopharyngeal Carcinoma, Chemotherapy, Radiotherapy, PD-1 Treatment
DrugToripalimab
Sun Yat-sen University
Phase 3
226
Guangzhou, Shaoguan, Zhongshan, Zhuhai, Wuzhou
2020-07-03
Recruiting
Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer
NCT04688801Esophageal Cancer, Gastroesophageal Cancer, Immunotherapy, Adjuvant
The Second Hospital of Shandong University
Not applicable
200
Jinan
2020-07-01
Active, closed
Shanghai Jiao Tong University School of Medicine
Phase 4
1,200
Shanghai
2020-07-01
Active, closed
Xiangya Hospital of Central South University
Observational
100
Changsha
2020-07-01
Recruiting
Chinese University of Hong Kong
Observational
300
Hong Kong
2020-07-01
Recruiting
Xing Xie
Phase 1/2
50
Zhejiang
2020-07-01
Recruiting
Peking University
Phase 2
104
Beijing
2020-07
By invitation
Chinese Academy of Medical Sciences
Observational
407
Beijing
2020-07
Recruiting
Sun Yat-sen University
Not applicable
500
Guangzhou, Zhuhai, Nanchang
2020-06-30
Active, closed
Actelion
Phase 3
935
Beijing, Changsha, Chengdu, Chongqing, Guangzhou, Shanghai, Shenyang, Tianjin
2020-06-30
Active, closed
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
22
Shanghai
2020-06-30
Recruiting
Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology
NCT05847894Pulmonary Diseases, Ophthalmological Diagnostic Techniques, Artificial Intelligence
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
10,000
Guangzhou, Shenzhen
2020-06-29
Active, closed
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
530
Nanjing
2020-06-29
Recruiting
Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma
NCT04376866Recurrent Nasopharyngeal Carcinoma
DrugsJS001·Toripalimab
Cancer Hospital of Guangxi Medical University
Phase 3
204
Nanning
2020-06-28
Active, closed
BioRay Pharmaceutical Co., Ltd.
Phase 3
408
Qingdao
2020-06-28
Not yet open
Fudan University
Phase 2
222
Shanghai
2020-06-22
Active, closed
Eli Lilly and Company
Phase 3
996
Hefei, Chongqing, Xiamen, Foshan, Guangzhou, Wuhan, Changsha, Changzhou
2020-06-22
Recruiting
First Affiliated Hospital, Sun Yat-Sen University
Observational
1,000
Guangzhou, Macao
2020-06-20
Active, closed
Sanofi
Phase 3
337
Hangzhou, Nanchang, Shanghai, Shenyang, Tianjin
2020-06-16
Active, closed
Epizyme, Inc.
Phase 3
599
Fuzhou, Xiamen, Guiyang, Zhejiang, Shijiazhuang, Zhengzhou, Changsha, Changchun
2020-06-11
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2
81
Nanjing
2020-06-09
Recruiting
Third Affiliated Hospital, Sun Yat-Sen University
Not applicable
200
Guangzhou
2020-06-04
Recruiting
Beijing Immunochina Medical Science & Technology Co., Ltd.
Phase 1/2
52
Beijing
2020-06-04
Recruiting
TAES for FPVCs: a Pragmatic, Randomized Controlled Trial
NCT04415203Premature Ventricular Complexes
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not applicable
90
Beijing
2020-06-04
Active, closed
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2
76
Guangzhou
2020-06-03
Active, closed
AstraZeneca
Phase 2
452
Chengdu, Guangzhou, Hefei, Shanghai, Shenyang, Wuhan, Zhengzhou
2020-06-03
Recruiting
National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
NCT05437965Coronary Artery Disease, Arteritis, In-Stent Stenosis (Restenosis) of Coronary Artery Stent
China National Center for Cardiovascular Diseases
Observational
1,000
Beijing
2020-06-03
Recruiting
Peking Union Medical College Hospital
Phase 2
60
Beijing
2020-06-03
Recruiting
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
NCT04187443Diabetic Macular Edema, Macular Edema, Type 2 Diabetes With Diabetic Macular Edema, Type 1 Diabetes With Diabetic Macular Edema
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
Phase 1
45
Changsha, Chengdu, Shanghai
2020-06-02
Active, closed
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
61
Tianjin
2020-06-01
Recruiting
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
300
Guangzhou
2020-06-01
Active, closed
Postoperative Infections and Immune Profiles in Patients Undergoing LVAD Implantation
NCT07255716Infection, Driveline Heart-assisted Device Related Infection, Pneumonia, Sepsis
China National Center for Cardiovascular Diseases
Observational
120
Beijing
2020-06-01
Recruiting
Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients
NCT04433455Hemodialysis, Cognitive Impairment, Cerebrovascular Disorders
Huashan Hospital
Observational
20
Shanghai
2020-06-01
By invitation
Tianjin Medical University Eye Hospital
Observational
100,000
Tianjin
2020-06-01
Recruiting
The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)
NCT05477979Lung Cancer, Psychological Stress, Immune Checkpoint Inhibitors, Cancer, Treatment-Related
Second Xiangya Hospital of Central South University
Observational
750
Changsha
2020-06-01
Recruiting
The Second Hospital of Shandong University
Not applicable
800
Jinan
2020-06-01
Not yet open
Peking Union Medical College Hospital
Observational
300
Beijing
2020-06
Active, closed
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
NCT04764227Esophagus Cancer, Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Radiation Therapy
DrugsPaclitaxel·Carboplatin
Fudan University
Phase 2
70
Shanghai
2020-05-30
Active, closed
Shanghai Jiao Tong University School of Medicine
Phase 2
216
Shanghai
2020-05-30
Active, closed
BeiGene
Phase 3
453
Hefei, Beijing, Fuzhou, Quanzhou, Xiamen, Guangzhou, Jiangmen, Shantou
2020-05-29
Active, closed
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,872
Hangzhou, Beijing, Guangdong, Huzhou, Jinan, Jinhua, Kunming, Nanchang
2020-05-29
Recruiting
Capital Medical University
Observational
6,000
Beijing
2020-05-28
Recruiting
Zhiyong Huang
Phase 1
16
Wuhan
2020-05-27
Recruiting
Chongqing University Cancer Hospital
Not applicable
120
Chongqing
2020-05-26
Active, closed
Prospective Randomized Evaluation of Decompressive Ipsilateral Craniectomy for Traumatic Acute Epidural Hematoma
NCT04261673Epidural Hematoma, Brain Herniation, Decompressive Craniectomy, Craniotomy
RenJi Hospital
Not applicable
120
Shanghai
2020-05-23
Recruiting
Peking University People's Hospital
Observational
1,000
Beijing
2020-05-21
Active, closed
Fudan University
Phase 2
367
Shanghai
2020-05-20
Recruiting
Ze-yang Ding, MD
Observational
300
Quanzhou, Wuhan
2020-05-19
Recruiting
Third Affiliated Hospital, Sun Yat-Sen University
Observational
300
Guangzhou
2020-05-15
Active, closed
Beijing Airdoc Technology Co., Ltd.
Not applicable
50
Ningbo
2020-05-13
Recruiting
Real World Study of Classic Infectious Disease
NCT04020536Brucelloses, Epidemic Hemorrhagic Fever, Kala-Azar
Huashan Hospital
Observational
10,000
Shanghai
2020-05-13
Recruiting
Peking University People's Hospital
Not applicable
654
Beijing
2020-05-12
Recruiting
xuexin he
Not applicable
183
Hangzhou, Jiaxing, Lishui
2020-05-09
Active, closed
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
2,400
Beijing
2020-05-08
Active, closed
GlaxoSmithKline
Phase 3
494
Beijing, Jinan, Shenyang
2020-05-07
Active, closed
AstraZeneca
Phase 3
805
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Guangdong, Guangzhou
2020-05-05
Active, closed
ShangHai Ji Ai Genetics & IVF Institute
Not applicable
828
Shanghai
2020-05-04
Active, closed
Time Restricted Eating on Impaired Glucose Regulation(TRIG Trial)
NCT03802253Impaired Glucose Regulation, Overweight/Obese, Time-restricted Eating
The First Affiliated Hospital of Xiamen University
Not applicable
142
Xiamen
2020-05-04
Recruiting
Sun Yat-sen University
Phase 3
207
Guangzhou
2020-05-03
Recruiting
Peking University Shenzhen Hospital
Phase 3
50
Shenzhen
2020-05-01
Recruiting
Guangdong Provincial People's Hospital
Observational
600
Guangzhou, Guanzhou
2020-05-01
Recruiting
Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension
NCT05595200Sleep Apnea, Obstructive Sleep Apnea, Pulmonary Hypertension, Epidemiology
Chinese Pulmonary Vascular Disease Research Group
Observational
480
Beijing
2020-05-01
Recruiting
Chinese Obesity and MEtabolic Surgery Database (COMES Database)
NCT06275061Obesity, Metabolic Surgery, Bariatric Surgery, Weight Loss
Jinan University Guangzhou
Observational
1,000,000
Guangzhou
2020-05-01
Recruiting
Tongji Hospital
Observational
200
Wuhan
2020-05-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
30
Beijing
2020-05-01
Recruiting
China National Center for Cardiovascular Diseases
Not applicable
400
Beijing
2020-04-30
Active, closed
Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies
NCT03932331Phase I: Relapsed or Refractory B-cell Malignancies, Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma, Phase II Cohort B: Relapsed or Refractory Chronic Lymphocytic Leukemia
DrugAcalabrutinib
AstraZeneca
Phase 1/2
105
Beijing, Changchun, Changsha, Changzhou, Chengdu, Fuzhou, Haikou, Hangzhou
2020-04-29
Recruiting
Shanghai Bovax Biotechnology Co., Ltd.
Phase 3
8,000
Liuzhou
2020-04-28
Recruiting
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Observational
100
Shanghai
2020-04-26
Active, closed
Xynomic Pharmaceuticals, Inc.
Phase 2
87
Beijing, Changchun, Chengdu, Dalian, Fuzhou, Guangzhou, Hainan, Hangzhou
2020-04-22
Recruiting
Effectiveness of Bariatric Surgery for NAFLD/NASH
NCT04366999Bariatric Surgery Candidate, NAFLD, NASH With Fibrosis
Beijing Friendship Hospital
Observational
320
Beijing
2020-04-21
Recruiting
Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
NCT04280822Esophageal Cancer, Surgery, Neoadjuvant Treatment, Survival
Henan Cancer Hospital
Phase 3
400
Zhengzhou
2020-04-21
Recruiting
Fudan University
Not applicable
94
Shanghai
2020-04-21
Active, closed
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
60
Guangzhou, Chengdu, Hangzhou
2020-04-17
Active, closed
AstraZeneca
Phase 3
818
Baoding, Beijing, Changchun, Chongqing, Dalian, Foshan, Gongshu District, Guangzhou
2020-04-16
Recruiting
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation
NCT04322890Non Small Cell Lung Cancer, EGFR Gene Mutation, ALK Gene Mutation, ROS1 Gene Mutation
DrugsGefitinib·Brigatinib·Erlotinib·Entrectinib
Hunan Province Tumor Hospital
Phase 2
6,000
Changsha
2020-04-16
Recruiting
The Taiwan OSA Study
NCT07302685Obstructive Sleep Apnea
China Medical University Hospital
Observational
7,000
2020-04-10
Recruiting
Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery
NCT04209218Lung Cancer, Surgery, Blood Pressure Management, Dexamethasone
DrugDexamethasone
Peking University First Hospital
Not applicable
1,988
Beijing
2020-04-07
Active, closed
Bayer
Observational
54
Many Locations
2020-04-03
Active, closed
Qianfoshan Hospital
Observational
400
Jinan
2020-04-02
Active, closed
GlaxoSmithKline
Phase 3
325
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Nanchang, Shenzhen, Tianjin
2020-04-02
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
1,000
Guangzhou
2020-04-01
Recruiting
Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
NCT04544969Circulating Tumor Cell, Nasopharyngeal Carcinoma, Distant Metastases.Clinical, Effects of Chemotherapy
Sun Yat-sen University
Observational
50
Guangzhou
2020-04-01
Recruiting
Peking University Third Hospital
Not applicable
834
Beijing
2020-04-01
Recruiting
Zhongshan People's Hospital, Guangdong, China
Observational
40,000
Zhongshan, Wuzhou
2020-04-01
Recruiting
Cognitive Impairment in Ageing People
NCT04360200MCI, Alzheimer Disease, VAD - Vascular Dementia, Cognitive Impairment
Yamei Tang
Observational
5,000
Guangzhou
2020-04-01
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou
2020-03-30
Recruiting
Yanhong Deng
Phase 3
582
Guangzhou
2020-03-27
Recruiting
Hunan Province Tumor Hospital
Observational
800
Changsha
2020-03-24
Recruiting
Hunan Province Tumor Hospital
Phase 2/3
1,200
Changsha
2020-03-24
Recruiting
Tongji Hospital
Not applicable
50
Wuhan
2020-03-22
Active, closed
The First Hospital of Jilin University
Phase 2
30
Changchun
2020-03-20
Recruiting
National Registry of IRPF in China
NCT04314323Idiopathic Retroperitoneal Fibrosis
Peking Union Medical College Hospital
Observational
500
Beijing
2020-03-17
Active, closed
Eli Lilly and Company
Phase 2
77
Beijing, Guangzhou, Changsha, Changchun, Jinan, Shanghai, Tianjin, Hangzhou
2020-03-16
Recruiting
Early Detection of Advanced Adenomas and Colorectal Cancer
NCT06342440Colorectal Cancer, Colorectal Neoplasms, Colorectal Polyp, Colorectal Adenocarcinoma
City of Hope Medical Center
Observational
2,000
Dalian
2020-03-15
Recruiting
Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis
NCT05550077Intracranial Atherosclerosis, Optical Coherence Tomography, Plaque, Atherosclerotic, Artery Stenosis
jiaoliqun
Observational
400
Beijing
2020-03-15
Recruiting
Circulating Non-coding RNA in Acute Ischemic Stroke With Endovascular Treatment (EVTRNA)
NCT04230785Stroke, Acute, Stroke, Ischemic, Endovascular Treatment
Nanjing First Hospital, Nanjing Medical University
Observational
300
Nanjing
2020-03-15
Active, closed
National Health Research Institutes, Taiwan
Not applicable
51
2020-03-12
Active, closed
Sun Yat-sen University
Phase 2
68
Guangzhou
2020-03-12
Recruiting
CADASIL Registry Study
NCT04310098Cadasil
Bin Cai
Observational
1,000
Fuzhou
2020-03-09
Active, closed
Fudan University
Phase 3
808
Shanghai
2020-03-05
Recruiting
Amgen
Phase 1
479
Beijing, Guangzhou, Nanchang, Shanghai, Hangzhou, Nanjing, Wenzhou
2020-03-04
Recruiting
Reduced Port Laparoscopic Gastrectomy for Gastric Cancer
NCT04295473Laparoscopic, Gastrectomy
Nanchong Central Hospital
Not applicable
160
Nanchong
2020-03-02
Active, closed
Hebei Medical University Fourth Hospital
Phase 2/3
113
Shijiazhuang
2020-03-01
Recruiting
Sun Yat-sen University
Phase 3
212
Guangzhou, Beijing, Chengdu, Fuzhou, Guiyang, Hangzhou, Nanchang, Nanning
2020-03-01
Recruiting
A Pilot Study in Severe Patients With Takayasu Arteritis.
NCT04300686Takayasu Arteritis, Tocilizumab, Adalimumab, Treatment
DrugsAdalimumab·Tocilizumab
Shanghai Zhongshan Hospital
Phase 4
40
Shanghai
2020-03-01
Recruiting
Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children
NCT06530004Nephrotic Syndrome, Rituximab, Children, Efficacy
DrugRituximab
The First Affiliated Hospital of Xiamen University
Observational
50
Xiamen
2020-03-01
Recruiting
The Application of T1 Mapping in Real-World
NCT07354646Myocardial Infarction (MI), Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Arrhythmogenic Cardiomyopathy
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
2,000
Beijing
2020-03-01
Recruiting
Jiawei Jiang
Not applicable
100
Nantong
2020-03-01
Active, closed
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
NCT04152499Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma
DrugSacituzumab tirumotecan
Klus Pharma Inc.
Phase 1/2
1,410
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Guangzhou
2020-02-28
Recruiting
Abbisko Therapeutics Co, Ltd
Phase 1
200
Bengbu, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Weifang, Haerbin
2020-02-26
Recruiting
Nanjing First Hospital, Nanjing Medical University
Observational
3,000
Nanjing
2020-02-25
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
1,850
Hangzhou
2020-02-20
Active, closed
Eli Lilly and Company
Phase 3
261
Beijing, Guangzhou, Harbin, Wuhan, Changsha, Changzhou, Changchun, Shanghai
2020-02-17
Not yet open
RAMPS VS SRPS for Pancreatic Body and Tail Adenocarcinoma
NCT04253847Radical Antegrade Modular Pancreatosplenectomy
Ruijin Hospital
Not applicable
224
Shanghai
2020-02-15
Active, closed
Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus
NCT04276532Middle-high Risk Endometrial Cancer, Sentinel Lymph Node Sampling, Prognosis
Xiaojun Chen
Not applicable
780
Shanghai
2020-02-13
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Harbin, Zhengzhou
2020-02-11
Active, closed
AbbVie
Phase 3
56
Beijing, Guangzhou, Shenzhen, Shenyang, Shanghai
2020-02-04
Recruiting
Chinese Academy of Medical Sciences
Phase 2
286
Beijing
2020-02-01
Not yet open
Choroidal Change on OCTA in Eyes With High Myopia
NCT04255524Myopia, Progressive, Choroid Disease
The First Affiliated Hospital with Nanjing Medical University
Not applicable
200
Nanjing
2020-02-01
Recruiting
Peking University Shenzhen Hospital
Phase 4
140
Shenzhen
2020-02-01
Recruiting
Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
NCT05406999Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer, Intense Endocrine Therapy
DrugsRezvilutamide·Apalutamide·Abiraterone acetate·Enzalutamide
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
900
Nanjing
2020-02-01
Active, closed
Sun Yat-sen University
Phase 2
246
Guangzhou
2020-01-31
Active, closed
Bayer
Observational
805
Multiple Locations
2020-01-30
Active, closed
Hoffmann-La Roche
Phase 2/3
325
Beijing, Changchun, Chongqing, Fujian, Guangzhou, Hangzhou, Harbin, Shanghai
2020-01-29
Recruiting
Peking Union Medical College Hospital
Phase 4
90
Beijing
2020-01-21
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 2
170
Beijing, Chengdu, Dalian, Fuzhou, Guangzhou, Hangzhou, Harbin, Lanzhou
2020-01-20
Active, closed
Henan Cancer Hospital
Phase 2
25
Zhengzhou
2020-01-20
Recruiting
Abbisko Therapeutics Co, Ltd
Phase 1
276
Beijing, Guangdong, Shijiazhuang, Zhengzhou, Nanjing, Shenyang, Shanghai, Xian
2020-01-20
Active, closed
AstraZeneca
Phase 3
155
Beijing, Changchun, Changsha, Changzhou, Guangzhou, Guiyang, Hangzhou, Hefei
2020-01-20
Active, closed
The First Affiliated Hospital of Soochow University
Phase 2
37
Suzhou
2020-01-19
Recruiting
A Prospective Cohort Study of IRPF in China
NCT04312854Idiopathic Retroperitoneal Fibrosis
Peking Union Medical College Hospital
Observational
500
Beijing
2020-01-17
Active, closed
BeOne Medicines
Phase 3
955
Beijing, Fuzhou, Quanzhou, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanjing
2020-01-16
Active, closed
Actelion
Phase 3
138
Beijing, Guangzhou, Qingdao, Shanghai, Shenyang
2020-01-16
Active, closed
Cho Pharma Inc.
Phase 1/2
37
2020-01-15
Recruiting
First Affiliated Hospital of Fujian Medical University
Phase 2/3
100
Fuzhou
2020-01-10
Recruiting
He Huang
Early Phase 1
72
Hangzhou
2020-01-08
Active, closed
Xynomic Pharmaceuticals, Inc.
Phase 1/2
12
Beijing, Hangzhou, Tianjin, Xuzhou
2020-01-08
Recruiting
The Second Hospital of Shandong University
Not applicable
100
Jinan
2020-01-07
Recruiting
Fudan University
Not applicable
320
Nanjing, Shanghai
2020-01-06
Recruiting
Carotid Revascularization for Radiation Induced Carotid Artery Stenosis
NCT05134246Radiation-induced Carotid Artery Stenosis
Xuanwu Hospital, Beijing
Observational
150
Beijing, Guangzhou
2020-01-05
Recruiting
Correlation Between Microbial Infection and Lumbar Degenerative Disease Based on High-throughput Gene Sequencing
NCT06075979Lumbar Degenerative Diseases, Gene Product Sequence Variation
HaoxuanZhang
Not applicable
200
Jinan
2020-01-02
By invitation
Liu Yang
Observational
900
Jinan
2020-01-01
Recruiting
Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa
NCT06926192Hidradenitis Suppurativa (HS), Hidradenitis Suppurativa (Acne Inversa), Secukinumab
Peking Union Medical College
Observational
100
Nanjing
2020-01-01
Recruiting
A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
NCT07176962Gall Bladder Cancer, Intrahepatic Cholangiocarcinoma (Icc), Extrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma
Yingbin Liu, MD, PhD, FACS
Observational
1,800
Shanghai
2020-01-01
Recruiting
Third Affiliated Hospital, Sun Yat-Sen University
Observational
45
Guangzhou
2020-01-01
Recruiting
Guangdong Provincial People's Hospital
Observational
6,500
Guangzhou
2020-01-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
168
Beijing, Guangzhou, Changsha, Hohhot, Shanghai, Xi’an, Chengdu, Hanzhou
2020-01-01
Recruiting
AI Recognition of Important Structures in Otolaryngological Surgery
NCT06726551Otolaryngological Diseases Requiring Mastoidectomy, Middle Ear Surgery, Endolymphatic Sac Surgery, Cochlear Implant, Labyrinthectomy, Petrous Apex Lesions, Facial Nerve Surgery, and Lateral Skull Base Tumors
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
1,000
Guangzhou
2020-01-01
Recruiting
Guangdong Provincial People's Hospital
Observational
6,000
Guangzhou
2020-01-01
Active, closed
Fudan University
Observational
890
Shanghai
2020-01-01
Recruiting
The Clinical Outcomes of the Modified Broström vs Anatomic Reconstruction Operation in CLAI and GJL
NCT05196906Ankle Sprains, Instability, Joint, Joint Hypermobility
Peking University Third Hospital
Observational
100
Beijing
2020-01-01
Active, closed
Beijing Anzhen Hospital
Observational
1,400
Beijing
2020-01-01
Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
31
Suzhou
2020-01-01
Recruiting
Fudan University
Phase 4
800
Fuzhou, Zhengzhou, Wuhan, Hohhot, Shanghai, Shanxi, Hangzhou, Beijing
2020-01-01
Recruiting
Peking University Shougang Hospital
Observational
350
Beijing
2020-01-01
Recruiting
Myocardialbridge Bypass Graft Surgery Efficacy Verification
NCT06857838Myocardial Bridge of Coronary Artery, Myocardial Bridge, Myocardial Bridging, Myocardial Infarction
Xi'an International Medical Center Hospital
Not applicable
500
Xi'an
2020-01-01
Recruiting
AAA-CTA Cohort Registry
NCT07039825Abdominal Aortic Aneurysm, Image
RenJi Hospital
Observational
1,000
Shanghai
2020-01-01
By invitation
Qianfoshan Hospital
Not applicable
60
Jinan
2020-01-01
Active, closed
Shandong Provincial Hospital
Not applicable
2,000
Jinan
2020-01-01
Recruiting
Effect and Mechanism of ALPPS Operation on Liver Regeneration
NCT07142213Hepato Cellular Carcinoma (HCC), Hepatobiliary Cancers, Liver Cancer, Liver Regeneration
Haitao Zhao, MD
Observational
50
Beijing
2020-01-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
1,200
Hangzhou
2020-01-01
Recruiting
Basic and Clinical Research of Pregnancy-Induced Hypertension
NCT07464379Pregnancy-induced Hypertension
Second Affiliated Hospital of Wenzhou Medical University
Observational
100
Wenzhou
2020-01-01
Active, closed
Peking University Third Hospital
Observational
1,600
Beijing
2020-01-01
Recruiting
Affiliated 2 Hospital of Nantong University
Observational
300
Nantong
2020-01-01
Active, closed
Guangdong Provincial People's Hospital
Observational
224
Guangzhou
2020-01-01
Recruiting
Sun Yat-sen University
Phase 3
346
Guangzhou
2020-01-01
Recruiting
Shuotongo Ureteroscopy for Upper Urinary Tract Stones
NCT05712785Urinary Calculi, Ureterocele
Handan First Hospital
Not applicable
200
Handan
2020-01-01
Recruiting
Guangdong Provincial People's Hospital
Observational
50,000
Guangzhou
2020-01-01
Recruiting
Sun Yat-sen University
Observational
700
Guangzhou
2020-01-01
Active, closed
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
10,000
Beijing
2020-01-01
By invitation
Zhijun Bao
Observational
220
Shanghai
2020-01-01
By invitation
Beijing Tongren Hospital
Observational
3,760
Beijing
2020-01-01
Recruiting
Linear Stapler Versus Circular Stapler in Esophagojejunostomy
NCT05360069Postoperative Complications, Operative Time, Hospital Costs
Nanchong Central Hospital
Not applicable
100
Nanchong
2020-01-01
Active, closed
The First People's Hospital of Neijiang
Not applicable
80
Neijiang
2020-01-01
Recruiting
Shanghai Jiao Tong University School of Medicine
Not applicable
200
Shanghai
2020-01-01
Recruiting
Chinese Pulmonary Vascular Disease Research Group
Observational
5,000
Beijing
2020-01-01
Recruiting
Change of Hemodynamics and Cerebral Functions After Carotid Artery Revascularization
NCT05539781Carotid Artery Diseases, Carotid Artery Stenosis, Cerebrovascular; Disorder, Arteriosclerotic, Cardiovascular Diseases
Beijing Friendship Hospital
Observational
200
Beijing
2020-01-01
Recruiting
Xiaolin Chen, MD
Observational
10,000
Beijing
2020-01-01
Recruiting
Prognostic Model of Hypertension
NCT06160921Hypertension
Xinjiang Medical University
Observational
50,000
Ürümqi
2020-01-01
Active, closed
JiAngSu Maternal and INfant HEalth Database
NCT06641479Pregnant Women, Children
Yang Zhao
Observational
1,570,360
Nanjing
2020-01-01
Recruiting
CAES for Internal Hemorrhoids and Rectal Prolapse
NCT04169152Internal Hemorrhoid, Rectal Prolapse
Faming Zhang
Observational
10,000
Nanjing
2019-12-30
Active, closed
Pfizer
Phase 3
1,068
Hefei, Beijing, Fuzhou, Wuhan, Changsha, Nanjing, Nantong, Suzhou
2019-12-30
Recruiting
Chinese PLA General Hospital
Not applicable
1,134
Beijing
2019-12-26
Recruiting
Cardiac Magnetic Resonance for Risk Stratification in Dilated Cardiomyopathy
NCT04990297Dilated Cardiomyopathy, Single-center Study
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
2,500
Beijing
2019-12-24
Active, closed
Impact Therapeutics, Inc.
Phase 3
404
Guanzhou, Shanghai
2019-12-24
Active, closed
Fudan University
Phase 3
1,560
Shanghai
2019-12-20
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 1
161
Beijing
2019-12-20
Active, closed
Transforaminal Lumbar Interbody Fusion (TLIF)
NCT04073563Degenerative Disease of the Lumbosacral Spine
Medtronic Spinal and Biologics
Not applicable
600
Beijing, Chengdu, Chongqing
2019-12-19
Active, closed
Ruijin Hospital
Phase 2/3
580
Baoding, Beijing, Changsha, Changzhi, Chengdu, Guiyang, Haikou, Hangzhou
2019-12-18
Recruiting
Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
NCT04254263Locally Advanced Breast Cancer
DrugPyrotinib
RenJi Hospital
Phase 3
316
Shanghai
2019-12-16
Recruiting
Hui-Sheng Chen
Not applicable
30
Shenyang
2019-12-15
Active, closed
CStone Pharmaceuticals
Phase 3
534
Bengbu, Hefei, Beijing, Fuzhou, Xiamen, Foshan, Guangzhou, Nanning
2019-12-13
Not yet open
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
136
Foshan
2019-12-13
Active, closed
The Effectiveness and Safety of Resective Epilepsy Surgery for TRE
NCT04198181Tuberous Sclerosis Complex, Epilepsy
Beijing Children's Hospital
Observational
200
Beijing
2019-12-12
Recruiting
Sun Yat-Sen University Cancer Center
Not applicable
232
Guangzhou
2019-12-11
Active, closed
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
NCT04188548Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Endometrial Cancer
DrugsImlunestrant·Alpelisib·Everolimus·Abemaciclib
Eli Lilly and Company
Phase 1
379
2019-12-10
Recruiting
Study of Post-anesthesia Management in Patients Undergoing Neurosurgery
NCT04362709Anesthesia, Neurosurgery, Complication
Beijing Tiantan Hospital
Observational
10,000
Beijing
2019-12-02
Recruiting
Huazhong University of Science and Technology
Observational
400
Wuhan
2019-12-02
Recruiting
Alexion Pharmaceuticals, Inc.
Observational
500
Chengdu, Beijing, Changchun, Guangzhou, Jinan, Nanchang, Qingdao, Shijiazhuang
2019-12-02
Active, closed
Ruijin Hospital
Observational
76
Shanghai
2019-12-01
Active, closed
Chen Xiaoping
Not applicable
1,076
Wuhan
2019-12-01
Recruiting
Shanghai Institute of Hypertension
Observational
4,500
Shanghai
2019-12-01
Active, closed
Xijing Hospital
Not applicable
10
Xi'an
2019-12-01
By invitation
Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer
NCT06849362Metastatic Colorectal Cancer (CRC), MSS Metastatic Colorectal Cancer, Immunotherapy
DrugBevacizumab
Yue Gou
Observational
200
Changsha
2019-12-01
Active, closed
Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy
NCT04384627Nasopharyngeal Carcinoma, Induction Chemotherapy, Radiotherapy
Sun Yat-sen University
Phase 3
445
Foshan, Zhongshan
2019-12-01
Not yet open
Beijing Anzhen Hospital
Observational
10,000
Beijing
2019-12
Recruiting
ctDNA Monitoring in Early Breast Cancer
NCT04353557Breast Cancer
Geneplus-Beijing Co. Ltd.
Observational
200
Chongqing
2019-11-29
Recruiting
Circulating Non-coding RNA in Acute Ischemic Stroke (AISRNA)
NCT04175691Acute Stroke, Ischemic Stroke
Nanjing First Hospital, Nanjing Medical University
Observational
500
Nanjing
2019-11-24
Recruiting
Hebei Medical University Fourth Hospital
Phase 2
520
Shijiazhuang
2019-11-20
Recruiting
Hebei Medical University Fourth Hospital
Phase 2
414
Shijiazhuang
2019-11-20
Recruiting
Cerebral Small Vessel Disease Registry Study
NCT04318119Cerebral Small Vessel Diseases
Bin Cai
Observational
3,000
Fuzhou
2019-11-18
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Beijing, Tianjin, Chongqing, Guangzhou, Harbin, Zhengzhou, Wuhan, Suzhou
2019-11-13
Active, closed
Geneplus-Beijing Co. Ltd.
Observational
757
Beijing, Shenzhen, Zhengzhou, Changsha, Nanjing, Changchun, Jinzhou, Chengdu
2019-11-12
Active, closed
AbbVie
Phase 1
85
2019-11-08
Recruiting
Celgene
Phase 2
99
Guangzhou, Shenzhen, Nanning, Chengdu
2019-11-07
Active, closed
Bristol-Myers Squibb
Phase 3
461
Beijing, Fuzhou, Hubei Sheng, Changsha, Shanghai, Chengdu, Hangzhou
2019-11-05
Recruiting
Navy General Hospital, Beijing
Observational
200
Beijing
2019-11-05
Recruiting
Tang-Du Hospital
Observational
200
Xi'an
2019-11-04
Recruiting
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
NCT06255197Lung Cancer, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Non Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
60,000
Beijing
2019-11-04
Recruiting
China Research for Severe Spontaneous Intracerebral Hemorrhage（CRISIH）
NCT05975398Severe Spontaneous Intracranial Hemorrhage, Long-term Antiplatelet Treatment, Emergency Surgery, Complications
Beijing Tiantan Hospital
Observational
2,000
Beijing
2019-11-01
Recruiting
Peking University Third Hospital
Observational
3,000
Beijing
2019-11-01
Recruiting
The Effect of PAP on ISSHL Comorbided With OSA
NCT04192656Sudden Hearing Loss, Obstructive Sleep Apnea
DrugMethylprednisolone
Beijing Tsinghua Chang Gung Hospital
Phase 4
102
Beijing
2019-11-01
Active, closed
Novartis Pharmaceuticals
Phase 1
120
Guangzhou
2019-10-30
Recruiting
Ruijin Hospital
Phase 2
30
Shanghai
2019-10-30
Active, closed
Capital Medical University
Phase 3
707
Beijing
2019-10-29
Recruiting
A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies
NCT06550713Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)
DrugAzacitidine
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
100
Beijing, Shijiazhuang, Harbin, Shanghai, Chengdu, Tianjin
2019-10-22
Recruiting
Henan Cancer Hospital
Phase 3
456
Zhengzhou
2019-10-22
Recruiting
Comparison of FDG and FAPI in Patients With Various Types of Cancer
NCT04416165Tumor, Solid, Positron-Emission Tomography, Metastasis
The First Affiliated Hospital of Xiamen University
Not applicable
3,000
Xiamen
2019-10-20
Recruiting
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
NCT03983226Ovarian Cancer Recurrent, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
DrugNiraparib
Shanghai Gynecologic Oncology Group
Phase 2
167
Shanghai, Guangzhou, Hangzhou
2019-10-18
Recruiting
Overweight and Obesity and Puberty Development Cohort Study
NCT04113070Precocious Puberty, Overweight and Obesity
Shanghai Jiao Tong University School of Medicine
Observational
14,100
Shanghai
2019-10-11
Active, closed
Acute Health Effects of Traffic-Related Air Pollution Exposure
NCT04153539Cardiovascular System, Respiratory System
Fudan University
Not applicable
69
Shanghai
2019-10-09
Active, closed
Sun Yat-sen University
Phase 2
34
Guangzhou
2019-10-09
Recruiting
The Second Hospital of Shandong University
Not applicable
350
Jinan
2019-10-08
Recruiting
Shanghai General Hospital, China
Observational
7,000
Shanghai
2019-10-08
Recruiting
Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis
NCT07614594Urothelial Carcinoma (UC), Upper Tract Urothelial Carcinoma, UTUC, Bladder Cancer (BC)
Henan Provincial People's Hospital
Observational
800
Zhengzhou
2019-10-08
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Tianjin, Xi'an, Hangzhou
2019-10-03
Recruiting
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
NCT03955445C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis
DrugIptacopan
Novartis Pharmaceuticals
Phase 3
225
Beijing, Shanghai
2019-10-03
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
Guangzhou, Zhanjiang, Zhengzhou, Changsha, Wuhan, Nanjing, Xuzhou, Nanchang
2019-10-02
Recruiting
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
400
Shanghai
2019-10-01
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
690
Hefei, Nanyang, Nantong, Xuzhou, Yancheng, Jinan, Shanghai, Hangzhou
2019-10-01
Recruiting
Chemoradiotherapy in Unresectable Esophageal Cancer
NCT04278287Esophageal Cancer, Chemoradiotherapy, Albumin-bound Paxlitaxel, Unresectable Malignant Neoplasm
DrugsAlbumin-Bound Paclitaxel·Nab-paclitaxel·Cisplatin
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2
105
Anyang, Changsha, Nanjing, Beijing
2019-10-01
Recruiting
Shengjing Hospital
Observational
500
Shenyang
2019-10-01
Recruiting
Self-reported Outcomes of Patients in ERAS Nursing
NCT05528484Enhanced Recovery After Surgery
The Second Hospital of Shandong University
Not applicable
600
Jinan
2019-10-01
Recruiting
Nanfang Hospital, Southern Medical University
Not applicable
60
Guangzhou
2019-09-29
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Ganzhou, Guangzhou
2019-09-26
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Beijing, Guangzhou, Changsha, Shanghai
2019-09-23
Recruiting
Mother-infant Microbiota Transmission and Its Link to the Health of the Baby
NCT04117321Gut Microbiome, Mother to Child Transmission
Chinese University of Hong Kong
Observational
20,000
Hong Kong
2019-09-23
Active, closed
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
NCT04083599Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Melanoma
DrugsGEN1042·Adrucil·Nab-paclitaxel·Pemetrexed
Genmab
Phase 1/2
350
2019-09-17
Active, closed
Astellas (Beijing) Pharmaceutical R&D Co., Ltd.
Phase 3
180
Beijing, Changchun, Changsha, Fuzhou, Guangzhou, Hangzhou, Nanchang, Shanghai
2019-09-11
Active, closed
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery
NCT04025840Pancreatic Cancer, Surgery, Epidural Block, Dexamethasone
DrugDexamethasone
Peking University First Hospital
Phase 4
260
Beijing
2019-09-11
Recruiting
Peking University Cancer Hospital & Institute
Not applicable
95
Beijing
2019-09-10
Active, closed
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
NCT03844048Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma
DrugsVenclexta·Venetoclax
AbbVie
Phase 3
165
2019-09-06
Recruiting
Low INR to Minimize Bleeding With Mechanical Valves Trial
NCT03636295Bleeding Post-mechanical Valve Replacement, Thromboembolism Post-mechanical Valve Replacement
DrugWarfarin
Population Health Research Institute
Phase 3
2,625
Beijing
2019-09-05
Active, closed
Janssen Research & Development, LLC
Phase 1
701
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan
2019-09-04
Recruiting
Fudan University
Not applicable
1,528
Shanghai
2019-09-04
Active, closed
A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors
NCT06239155Advanced Solid Tumors, Hepatocellular Carcinoma
DrugAST-3424
Ascentawits Pharmaceuticals, Ltd
Phase 1/2
51
Guangzhou, Zhengzhou, Nanjing, Shenyang, Shanghai, Hangzhou
2019-09-03
Recruiting
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
NCT04076449Cavernous Malformation, Cerebral, Cavernous Angioma, Cavernous Hemangioma, Cavernous Hemangioma of Brain
yuanli Zhao
Observational
200
Beijing
2019-09-03
Recruiting
Dan Liu
Observational
70
Tianjin
2019-09-01
Recruiting
The University of Hong Kong
Phase 3
784
Hong Kong
2019-09-01
Recruiting
Real World Study of End-stage Liver Disease in China
NCT04037995End Stage Liver DIsease, Complication
Huashan Hospital
Observational
10,000
Shanghai
2019-09-01
Recruiting
Southeast University, China
Observational
200
Nanjing
2019-09-01
Recruiting
Adjuvant Chemotherapy for High Malignant Prostate Cancer
NCT06864533Prostate Cancer, Radiation Therapy, Chemotherapy, Gleason Score
DrugsDocetaxel·Carboplatin
Peking University First Hospital
Observational
315
Beijing, Shenzhen, Baoding
2019-09-01
Recruiting
Second Affiliated Hospital of Guangzhou Medical University
Early Phase 1
11
Guangzhou
2019-09-01
Recruiting
Sun Yat-sen University
Phase 2
80
Guangzhou
2019-09-01
Recruiting
Shanghai Chest Hospital
Phase 3
176
Nanchang, Shanghai, Tianjin
2019-09-01
Recruiting
Children's Hospital of Fudan University
Not applicable
150
Shanghai
2019-09-01
Recruiting
Neoadjuvant Radiotherapy for Malignant Lacrimal Sac Tumors
NCT04016675Malignant Tumor of Lacrimal Drainage Structure
Eye & ENT Hospital of Fudan University
Not applicable
94
Shanghai
2019-09-01
Active, closed
Westlake Precision Birth Cohort
NCT04060056Diabetes, Gestational, Pregnancy in Diabetics, Intrauterine Hyperglycemia
Westlake University
Not applicable
2,001
Hangzhou
2019-08-30
Recruiting
CooperVision International Limited (CVIL)
Not applicable
250
Shanghai, Tianjin, Wenzhou
2019-08-29
Active, closed
Nanjing First Hospital, Nanjing Medical University
Observational
2,600
Nanjing
2019-08-28
Active, closed
Henan Cancer Hospital
Phase 2
60
Anyang, Luoyang, Zhengzhou
2019-08-26
Recruiting
A Registered Cohort Study on Brain Calcification
NCT04010201Brain Calcification
Wan-Jin Chen
Observational
2,000
Fuzhou
2019-08-25
Recruiting
University Hospital Muenster
Phase 3
683
Hong Kong
2019-08-23
Active, closed
Nanjing First Hospital, Nanjing Medical University
Not applicable
3,710
Nanjing
2019-08-20
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
540
Guangzhou
2019-08-20
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Observational
446
Yangpu
2019-08-20
Active, closed
BeOne Medicines
Phase 3
510
Beijing, Fuzhou, Quanzhou, Guangzhou, Harbin, Zhengzhou, Wuhan, Changsha
2019-08-20
Recruiting
Sclnow Biotechnology Co., Ltd.
Phase 1
242
Beijing
2019-08-15
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Beijing, Changchun, Chengdu, Guangzhou, Haikou, Hangzhou, Lanzhou, Nanjing
2019-08-15
Active, closed
Sanofi
Observational
1,860
Beijing, Changsha, Chongqing, Guangzhou, Harbin, Shanghai, Shenzhen, Suzhou
2019-08-15
Active, closed
Hoffmann-La Roche
Phase 1/2
498
Beijing, Jinan, Shanghai, Xiamen
2019-08-13
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Beijing, Guangzhou, Shanghai, Chengdu, Tianjin, Hangzhou
2019-08-12
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Hefei, Beijing, Guangzhou, Harbin, Changsha, Nanjing, Changchun, Xi'an
2019-08-09
Active, closed
Guangdong Association of Clinical Trials
Phase 2
316
Guangzhou
2019-08-08
Active, closed
Bristol-Myers Squibb
Phase 3
839
Hefei, Xiamen, Zhangzhou, Lanzhou, Foshan, Guangzhou, Nanning, Harbin
2019-08-05
Active, closed
Quantitative Flow Ratio (QFR) Guided Coronary Artery Bypass Grafting for Patients Undergoing Primary Valve Surgery With Concomitant Coronary Artery Disease
NCT03977129Primary Valvular Heart Disease With Comorbid Coronary Artery Disease, Planned to Undergo Elective On-pump Valve Surgery Due to Primary Mitral and/or Aortic Valvular Heart Disease
Ruijin Hospital
Not applicable
792
Hefei, Fuzhou, Zhengzhou, Changsha, Jinan, Qingdao, Shanghai, Tianjin
2019-08-04
Active, closed
Boston Scientific Corporation
Observational
2,000
Shanghai
2019-07-30
Recruiting
Real World Study of Chronic Viral Hepatitis
NCT04025944Hepatitis, Chronic
Huashan Hospital
Observational
10,000
Shanghai
2019-07-20
Active, closed
Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases
NCT07491211NSCLC (Advanced Non-small Cell Lung Cancer), Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Osimertinib, Stereotactic Radiation
DrugOsimertinib
Fudan University
Observational
300
Shanghai, Wuhan
2019-07-19
Active, closed
Betta Pharmaceuticals Co., Ltd.
Phase 1
54
Hangzhou
2019-07-18
Recruiting
Haihe Biopharma Co., Ltd.
Phase 1/2
183
Hefei, Beijing, Fuzhou, Guangzhou, Nanning, Haikou, Harbin, Zhengzhou
2019-07-15
Recruiting
The First Affiliated Hospital of Soochow University
Phase 1/2
50
Suzhou
2019-07-15
Active, closed
Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)
NCT03932136Clinical High Risk Syndrome of Psychosis
Shanghai Jiao Tong University School of Medicine
Phase 3
300
Guangzhou, Zhengzhou, Changsha, Suzhou, Shanghai, Shenzhen, Tianjin
2019-07-14
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
2,135
Shanghai
2019-07-12
Active, closed
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
NCT04008797Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms
DrugsE7386·Doxorubicin·Lenvatinib·Paclitaxel
Eisai Inc.
Phase 1/2
301
Beijing, Changchun, Fuzhou, Guangzhou, Jinan, Kunming, Shanghai, Shenzhen
2019-07-11
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou
2019-07-09
Recruiting
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
NCT04008329Amyotrophic Lateral Sclerosis
First Affiliated Hospital of Fujian Medical University
Observational
2,000
Fuzhou
2019-07-05
Active, closed
Ascentage Pharma Group Inc.
Phase 1
80
Guangzhou, Zhengzhou, Changchun
2019-07-04
Active, closed
AstraZeneca
Phase 3
587
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Haikou, Hangzhou
2019-07-02
Recruiting
Beijing Hospital
Not applicable
115
Beijing, Guangzhou, Harbin, Nanjing, Xuzhou, Changchun, Xi'an, Luzhou
2019-07-02
Recruiting
A Registered Cohort Study on Charcot-Marie-Tooth Disease
NCT04010188Charcot-Marie-Tooth Disease
Ning Wang, MD., PhD.
Observational
500
Fuzhou
2019-07-01
Recruiting
A Registered Cohort Study on Spastic Paraplegia
NCT04006418Spastic Paraplegia
Wan-Jin Chen
Observational
500
Fuzhou
2019-07-01
Recruiting
Huazhong University of Science and Technology
Observational
10,000
Wuhan
2019-07-01
Recruiting
A Registered Cohort Study on Duchenne Muscular Dystrophy
NCT04012671Duchenne Muscular Dystrophy
Ning Wang, MD., PhD.
Observational
2,000
Fuzhou
2019-07-01
Recruiting
A Registered Cohort Study on Wilson's Disease
NCT04012658Wilson's Disease
Wan-Jin Chen
Observational
2,000
Fuzhou
2019-07-01
Recruiting
Ning Wang, MD., PhD.
Observational
1,500
Fuzhou
2019-07-01
Recruiting
Chen Li
Observational
3,000
Chongqing, Haikou
2019-07-01
Recruiting
BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
NCT04162353Multiple Myeloma in Relapse, Refractory Multiple Myeloma, Plasmacytoid; Lymphoma
iCell Gene Therapeutics
Phase 1
12
Shenzhen, Chengdu
2019-07-01
Recruiting
A Registered Cohort Study on SMA
NCT04010604Spinal Muscular Atrophy
Wan-Jin Chen
Observational
2,000
Fuzhou
2019-07-01
Active, closed
The First Affiliated Hospital of Soochow University
Phase 2
60
Suzhou
2019-07-01
Active, closed
MAMMI-BB PET for Monitoring Response to Neoadjuvant Therapy in Breast Cancer
NCT07875244Breast Cancer, Neoadjuvant Therapy, Axilla; Breast
Fudan University
Not applicable
1,024
Shanghai
2019-06-27
Recruiting
Fengming Kong
Observational
5,000
Shenzhen
2019-06-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
6,000
Guilin, Changzhi, Yuncheng, Mianyang
2019-06-26
Active, closed
AstraZeneca
Phase 3
923
Beijing, Changchun, Changsha, Chengdu, Foshan, Guangzhou, Guiyang, Haikou
2019-06-25
Rows per page Showing 18001–18500 of 19187
Previous 35 36 37 38 39 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 8 November 2026. https://priyalifescience.com/clinical-trials-china?page=37

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,790 of the 19,187 studies in this register are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 3,998 have not yet opened recruitment, 2,715 are active but closed to new participants, and 684 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (423) Advanced Solid Tumors (187) Colorectal Cancer (179) Gastric Cancer (175) Hepatocellular Carcinoma (154) Advanced Solid Tumor (153) Non-Small Cell Lung Cancer (145) Solid Tumor (142) Acute Ischemic Stroke (140) Lung Cancer (135) Non-small Cell Lung Cancer (132) Pancreatic Cancer (131) Multiple Myeloma (128) Coronary Artery Disease (122) Prostate Cancer (110)
→

Browse trials by site location

Beijing (5576) Shanghai (3879) Guangzhou (3345) Hangzhou (1819) Wuhan (1343) Chengdu (1307) Nanjing (1211) Changsha (1154) Chongqing (1078) Fuzhou (1040) Tianjin (934) Zhengzhou (931) Hefei (896) Jinan (783) Changchun (639)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.